Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels

L. C. Smith-Thomas, P. S R Richardson, I. G. Rennie, I. Palmer, M. Boulton, C. Sheridan, S. MacNeil

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose. The aim of the study was to determine to what extent collagen gel contraction could be reduced by calcium and calmodulin antagonists and agents that elevate cyclic AMP in order to develop a pharmacological approach to prevent/ arrest RPE contraction of epiretinal membranes in proliferative vitreoretinopathy. We also explored a possible role of pigment in collagen gel contraction. Method. We measured RPE mediated contraction of 3D collagen gels in the presence and absence of the calcium and calmodulin antagonists TMB8, Verapamil and Tamoxifen and the cAMP elevating agents IBMX and Forskolin. The effect of pigment on collagen gel contraction was assessed by comparing gel contraction mediated by RPE cells re-pigmented with melanin with that mediated by unpigmented RPE. The effect of IBMX on RPE proliferation was assessed using a BrdU ELISA and the effects of IBMX on RPE cytoskeleton and cell shape were assessed using Actin and Cytokeratin immunocytochemistry. Results. We report that both cAMP elevating agents and calcium and calmodulin antagonists reduce RPE mediated collagen gel contraction. Cyclic AMP elevation was more effective than a reduction in calcium in reducing contraction. There were no significant advantages in combining both approaches. The presence of melanin had no effect on gel contraction. Calcium antagonists and particularly agents which elevate cAMP caused RPE cells in collagen gels to extend fewer and shorter processes. cAMP elevation in particular caused RPE cells to become more rounded and develop arborised cell processes. Immunostaining for actin and cytokeratin revealed changes in cytoskeletal organisation in response to IBMX in that cells contained less actin than untreated cells and concentrated cytokeratins more centrally. Conclusion. We have identified two possible pharmacological approaches which may provide a new direction for preventing or slowing down the development of PVR.

Original languageEnglish (US)
Pages (from-to)518-529
Number of pages12
JournalCurrent Eye Research
Volume21
Issue number1
StatePublished - 2000
Externally publishedYes

Fingerprint

Retinal Pigments
Cyclic AMP
Collagen
Gels
Epithelial Cells
Calcium
1-Methyl-3-isobutylxanthine
Calmodulin
Keratins
Actins
Melanins
Pharmacology
Epiretinal Membrane
Proliferative Vitreoretinopathy
Cell Shape
Colforsin
Bromodeoxyuridine
Tamoxifen
Verapamil
Cytoskeleton

Keywords

  • Calcium
  • Collagen gels
  • Cyclic AMP
  • Pigment
  • RPE

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Smith-Thomas, L. C., Richardson, P. S. R., Rennie, I. G., Palmer, I., Boulton, M., Sheridan, C., & MacNeil, S. (2000). Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels. Current Eye Research, 21(1), 518-529.

Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels. / Smith-Thomas, L. C.; Richardson, P. S R; Rennie, I. G.; Palmer, I.; Boulton, M.; Sheridan, C.; MacNeil, S.

In: Current Eye Research, Vol. 21, No. 1, 2000, p. 518-529.

Research output: Contribution to journalArticle

Smith-Thomas, LC, Richardson, PSR, Rennie, IG, Palmer, I, Boulton, M, Sheridan, C & MacNeil, S 2000, 'Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels', Current Eye Research, vol. 21, no. 1, pp. 518-529.
Smith-Thomas, L. C. ; Richardson, P. S R ; Rennie, I. G. ; Palmer, I. ; Boulton, M. ; Sheridan, C. ; MacNeil, S. / Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels. In: Current Eye Research. 2000 ; Vol. 21, No. 1. pp. 518-529.
@article{69f6af6137ea4b25aee0fb75049d988d,
title = "Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels",
abstract = "Purpose. The aim of the study was to determine to what extent collagen gel contraction could be reduced by calcium and calmodulin antagonists and agents that elevate cyclic AMP in order to develop a pharmacological approach to prevent/ arrest RPE contraction of epiretinal membranes in proliferative vitreoretinopathy. We also explored a possible role of pigment in collagen gel contraction. Method. We measured RPE mediated contraction of 3D collagen gels in the presence and absence of the calcium and calmodulin antagonists TMB8, Verapamil and Tamoxifen and the cAMP elevating agents IBMX and Forskolin. The effect of pigment on collagen gel contraction was assessed by comparing gel contraction mediated by RPE cells re-pigmented with melanin with that mediated by unpigmented RPE. The effect of IBMX on RPE proliferation was assessed using a BrdU ELISA and the effects of IBMX on RPE cytoskeleton and cell shape were assessed using Actin and Cytokeratin immunocytochemistry. Results. We report that both cAMP elevating agents and calcium and calmodulin antagonists reduce RPE mediated collagen gel contraction. Cyclic AMP elevation was more effective than a reduction in calcium in reducing contraction. There were no significant advantages in combining both approaches. The presence of melanin had no effect on gel contraction. Calcium antagonists and particularly agents which elevate cAMP caused RPE cells in collagen gels to extend fewer and shorter processes. cAMP elevation in particular caused RPE cells to become more rounded and develop arborised cell processes. Immunostaining for actin and cytokeratin revealed changes in cytoskeletal organisation in response to IBMX in that cells contained less actin than untreated cells and concentrated cytokeratins more centrally. Conclusion. We have identified two possible pharmacological approaches which may provide a new direction for preventing or slowing down the development of PVR.",
keywords = "Calcium, Collagen gels, Cyclic AMP, Pigment, RPE",
author = "Smith-Thomas, {L. C.} and Richardson, {P. S R} and Rennie, {I. G.} and I. Palmer and M. Boulton and C. Sheridan and S. MacNeil",
year = "2000",
language = "English (US)",
volume = "21",
pages = "518--529",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels

AU - Smith-Thomas, L. C.

AU - Richardson, P. S R

AU - Rennie, I. G.

AU - Palmer, I.

AU - Boulton, M.

AU - Sheridan, C.

AU - MacNeil, S.

PY - 2000

Y1 - 2000

N2 - Purpose. The aim of the study was to determine to what extent collagen gel contraction could be reduced by calcium and calmodulin antagonists and agents that elevate cyclic AMP in order to develop a pharmacological approach to prevent/ arrest RPE contraction of epiretinal membranes in proliferative vitreoretinopathy. We also explored a possible role of pigment in collagen gel contraction. Method. We measured RPE mediated contraction of 3D collagen gels in the presence and absence of the calcium and calmodulin antagonists TMB8, Verapamil and Tamoxifen and the cAMP elevating agents IBMX and Forskolin. The effect of pigment on collagen gel contraction was assessed by comparing gel contraction mediated by RPE cells re-pigmented with melanin with that mediated by unpigmented RPE. The effect of IBMX on RPE proliferation was assessed using a BrdU ELISA and the effects of IBMX on RPE cytoskeleton and cell shape were assessed using Actin and Cytokeratin immunocytochemistry. Results. We report that both cAMP elevating agents and calcium and calmodulin antagonists reduce RPE mediated collagen gel contraction. Cyclic AMP elevation was more effective than a reduction in calcium in reducing contraction. There were no significant advantages in combining both approaches. The presence of melanin had no effect on gel contraction. Calcium antagonists and particularly agents which elevate cAMP caused RPE cells in collagen gels to extend fewer and shorter processes. cAMP elevation in particular caused RPE cells to become more rounded and develop arborised cell processes. Immunostaining for actin and cytokeratin revealed changes in cytoskeletal organisation in response to IBMX in that cells contained less actin than untreated cells and concentrated cytokeratins more centrally. Conclusion. We have identified two possible pharmacological approaches which may provide a new direction for preventing or slowing down the development of PVR.

AB - Purpose. The aim of the study was to determine to what extent collagen gel contraction could be reduced by calcium and calmodulin antagonists and agents that elevate cyclic AMP in order to develop a pharmacological approach to prevent/ arrest RPE contraction of epiretinal membranes in proliferative vitreoretinopathy. We also explored a possible role of pigment in collagen gel contraction. Method. We measured RPE mediated contraction of 3D collagen gels in the presence and absence of the calcium and calmodulin antagonists TMB8, Verapamil and Tamoxifen and the cAMP elevating agents IBMX and Forskolin. The effect of pigment on collagen gel contraction was assessed by comparing gel contraction mediated by RPE cells re-pigmented with melanin with that mediated by unpigmented RPE. The effect of IBMX on RPE proliferation was assessed using a BrdU ELISA and the effects of IBMX on RPE cytoskeleton and cell shape were assessed using Actin and Cytokeratin immunocytochemistry. Results. We report that both cAMP elevating agents and calcium and calmodulin antagonists reduce RPE mediated collagen gel contraction. Cyclic AMP elevation was more effective than a reduction in calcium in reducing contraction. There were no significant advantages in combining both approaches. The presence of melanin had no effect on gel contraction. Calcium antagonists and particularly agents which elevate cAMP caused RPE cells in collagen gels to extend fewer and shorter processes. cAMP elevation in particular caused RPE cells to become more rounded and develop arborised cell processes. Immunostaining for actin and cytokeratin revealed changes in cytoskeletal organisation in response to IBMX in that cells contained less actin than untreated cells and concentrated cytokeratins more centrally. Conclusion. We have identified two possible pharmacological approaches which may provide a new direction for preventing or slowing down the development of PVR.

KW - Calcium

KW - Collagen gels

KW - Cyclic AMP

KW - Pigment

KW - RPE

UR - http://www.scopus.com/inward/record.url?scp=0033733271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033733271&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 518

EP - 529

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 1

ER -